Robotics & Machine Learning Daily News2024,Issue(Nov.28) :200-201.

Fujian Medical University Reports Findings in Personalized Medicine (Development of a novel disulfidptosis-correlated m6A/m1A/m5C/m7G gene signature to predict prognosis and therapeutic response for lung adenocarcinoma patients by integrate d…)

福建医科大学个性化教学报告药物(一种新的二硫中毒相关药物的研制m6A/m1A/m5C/m7G基因特征预测预后及治疗综合d评价肺腺癌患者的疗效…)

Robotics & Machine Learning Daily News2024,Issue(Nov.28) :200-201.

Fujian Medical University Reports Findings in Personalized Medicine (Development of a novel disulfidptosis-correlated m6A/m1A/m5C/m7G gene signature to predict prognosis and therapeutic response for lung adenocarcinoma patients by integrate d…)

福建医科大学个性化教学报告药物(一种新的二硫中毒相关药物的研制m6A/m1A/m5C/m7G基因特征预测预后及治疗综合d评价肺腺癌患者的疗效…)

扫码查看

摘要

由一名新闻记者-机器人与机器学习日报的工作人员新闻编辑每日新闻-药物和治疗的新研究-个性化医疗是一个热门话题报告根据《新闻周刊》编辑对福州的新闻报道,研究表明,“Lu NG腺癌(LUAD)代表着一个巨大的全球健康负担,必须改进患者管理的先进预后工具。RNA修饰NS(m6A,m1A,m5C、m7G和二硫下垂是一种新的细胞死亡机制,已成为有希望的生物标志物和癌症的治疗靶点》。

Abstract

By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of areport. According to news reporting ou t of Fuzhou, People’s Republic of China, by NewsRx editors,research stated, “Lu ng adenocarcinoma (LUAD) represents a significant global health burden, necessitating advanced prognostic tools for improved patient management. RNA modificatio ns (m6A, m1A,m5C, m7G), and disulfidptosis, a novel cell death mechanism, have emerged as promising biomarkers andtherapeutic targets in cancer.”

Key words

Fuzhou/People’s Republic of China/Asia/Adenocarcinoma/Cancer/Cyborgs/Drugs and Therapies/Emerging Technologies/G enetics/Health and Medicine/Lung Cancer/Lung Diseases and Conditions/Machine Learning/Oncology/Personalized Medicine/Personalized Therapy

引用本文复制引用

出版年

2024
Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN:
段落导航相关论文